DARREN ROTH: Open Payments
NPI 1164689519 · THORNTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 30 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $44 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $135 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Astellas Pharma US Inc | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
Products named: VRAYLAR, AIRSUPRA, AREXVY, JARDIANCE, CAPLYTA, Veozah, GEMTESA, Leqembi.
Industry payments across CO — which companies pay providers there.
